SEATTLE, April 10, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering NanoSphere Health Sciences Inc.'s (CSE:NSHS) (CSE:NSHS.CN) (CNSX:NSHS) recent announcement that the United States Patent and Trademark Office granted Patent No. 9,925,149 covering the core technology behind the production of its NanoSphere Delivery System™, which paves the way for commercialization of its breakthrough delivery technology.



Researchers might know that active pharmaceutical ingredients produce a certain result in cells, but they often face difficulty delivering those APIs to target areas within the body. Many of the most promising companies in the biotech and pharmaceutical spaces are focused on developing drug delivery technologies designed to bring precise doses of APIs to highly specific targets without being degraded by the liver, digestive system or other parts of the body.

NanoSphere Delivery System

NanoSphere Health Sciences’ NanoSphere Delivery System™ is one of the most important advancements for the non-invasive delivery of biological agents in over 25 years. By nanoencapsulating a broad range of bioactive compounds in a protective, lipid membrane, the delivery platform transports them rapidly and effectively into the bloodstream and cells, while also making the active ingredients safer and more bioavailable by delivering precise doses to target sites.

The cannabis industry may be legal across much of North America, but physicians and patients have struggled to accurately prescribe the drug even if they know it’s safe and efficacious. For example, researchers have found that the bioavailability of cannabinoids differs greatly between individuals and delivery methods. The company’s NanoSphere Delivery System™ can help bypass first-pass metabolism and enhance and stabilize the bioavailability of cannabinoids.

In addition to cannabis, the NanoSphere Delivery System™ can be applied to many different hard-to-absorb nutrients, such as fat-soluble vitamins, fatty acids, minerals, botanical extracts, and phytochemicals. The technology could help increase bioavailability of these agents compared to traditional methods without the need to swallow capsules or take tinctures. These benefits could be enormous in the multi-billion dollar nutraceutical industry.

Building an IP Portfolio

NanoSphere Health Sciences’ new patent broadly covers the formation and manufacturing of lipid, structural nanoparticles, which is the NanoSphere Delivery System™, for the delivery of cannabinoids, pharmaceuticals, nutraceuticals, cosmeceuticals, and other biological agents. In particular, the patent extends to its 16 forms of lipid nanoparticle structures, which can be applied across healthcare sectors for vastly improved delivery of active pharmaceutical ingredients.

“The granting of the patent for the NanoSphere Delivery System™ secures our position as a leader in advanced nanoparticle delivery,” said NanoSphere Health Sciences CEO Robert Sutton in the press release announcing the new patent. “Major industries have the potential to be reshaped and reimagined by our next-generation technology.”

With the new patent, NanoSphere Health Sciences will have long-term market exclusivity over the delivery platform. The company plans to license the patented NanoSphere Delivery System™ and its proprietary manufacturing process to select companies in its target industries to maximize commercialization. The patent also enables the company to develop its own product lines, including Evolve Formulas’ transdermal, intranasal, and intraoral cannabis applications.

Looking Ahead

NanoSphere Health Sciences Inc. (CSE:NSHS) (OTC:NSHSF) represents a compelling investment opportunity in the drug delivery space. With its new patent in place, the company is well-positioned to commercialize its breakthrough technology in both the cannabis industry and the wider nutraceutical and pharmaceutical industries. Keep an eye NanoSphere as it pursues opportunities in these potentially lucrative markets.

For more information, visit the company’s website at www.nanospherehealth.com.

Please follow the link to read the full article: http://www.cannabisfn.com/nanosphere-health-sciences-achieves-landmark-patent/

About CFN Media

CFN Media (CannabisFN) is the leading agency and financial media network dedicated to the global cannabis industry, helps companies operating in the space attract investors, capital, and publicity. Since 2013, private and public cannabis companies in the US and Canada have relied on CFN Media to grow and succeed.

Learn how to become a CFN Media client company, brand or entrepreneur: http://www.cannabisfn.com/featuredcompany

Download the CFN Media iOS mobile app to access the world of cannabis from the palm of your hand: https://itunes.apple.com/us/app/cannabisfn/id988009247?ls=1&mt=8

Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone: http://www.cannabisfn.com

Disclaimer

CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on http://www.cannabisfn.com (the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news.

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/

Contact:

Frank Lane

206-369-7050

Flane@Cannabisfn.com



